Literature DB >> 12397366

Cardiovascular effects of androgens.

Wolfgang Weidemann1, Hartmut Hanke.   

Abstract

In the process of atherosclerosis sex steroids play a complex role in the vascular vessel wall system. Although a number of experimental studies have clearly documented an atheroprotective effect of estrogens, in recent clinical studies, estrogen replacement therapy has failed to reduce cardiovascular mortality. The effects of androgens on the cardiovascular system and cardiovascular diseases are even more controversial. Whereas in the past, androgens were mainly believed to exert adverse effects on the cardiovascular system, recent studies in men have documented a number of beneficial actions of testosterone in the arterial vascular system. Androgens affect lipid metabolism (e.g., LDL and HDL cholesterol, Lp(a)) and hemostasis (e.g., platelet aggregation and fibrinolytic activity). In addition, several other physiological and pathophysiological processes in the arterial vessel wall are influenced by androgens. Acute hemodynamic effects of testosterone on coronary vasomotion and stress-test-induced ischemia were reported. Additionally, recent animal and in vitro studies have further documented an inhibitory effect of androgens on neointimal plaque formation. This review discusses different and, in part, contradictory effects of androgens on the cardiovascular system including potential signal transduction pathways in androgen target cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397366     DOI: 10.1111/j.1527-3466.2002.tb00086.x

Source DB:  PubMed          Journal:  Cardiovasc Drug Rev        ISSN: 0897-5957


  11 in total

1.  Androgen receptor gene and sex-specific Alzheimer's disease.

Authors:  Raffaele Ferrari; Saad Dawoodi; Merrill Raju; Avinash Thumma; Linda S Hynan; Shirin Hejazi Maasumi; Joan S Reisch; Sid O'Bryant; Marjorie Jenkins; Robert Barber; Parastoo Momeni
Journal:  Neurobiol Aging       Date:  2013-03-29       Impact factor: 4.673

Review 2.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

Review 3.  Testosterone, myocardial function, and mortality.

Authors:  Vittorio Emanuele Bianchi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

4.  Plasma dehydroepiandrosterone and risk of myocardial infarction in women.

Authors:  John H Page; Jing Ma; Kathryn M Rexrode; Nader Rifai; Joann E Manson; Susan E Hankinson
Journal:  Clin Chem       Date:  2008-05-01       Impact factor: 8.327

5.  Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine.

Authors:  Darla L Tharp; Isabelle Masseau; Jan Ivey; Venkataseshu K Ganjam; Douglas K Bowles
Journal:  Cardiovasc Res       Date:  2009-01-30       Impact factor: 10.787

6.  Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation.

Authors:  S Tsang; S Wu; J Liu; T M Wong
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

7.  Androgen action via testicular arteriole smooth muscle cells is important for Leydig cell function, vasomotion and testicular fluid dynamics.

Authors:  Michelle Welsh; Richard M Sharpe; Lindsey Moffat; Nina Atanassova; Philippa T K Saunders; Sigrid Kilter; Anders Bergh; Lee B Smith
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

8.  Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.

Authors:  C Erem; M Kocak; A Hacihasanoglu; M Yilmaz
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

9.  High-dose testosterone propionate treatment reverses the effects of endurance training on myocardial antioxidant defenses in adolescent male rats.

Authors:  Ewa Sadowska-Krępa; Barbara Kłapcińska; Sławomir Jagsz; Andrzej Sobczak; Stanisław J Chrapusta; Małgorzata Chalimoniuk; Paweł Grieb; Stanisław Poprzęcki; Józef Langfort
Journal:  Cardiovasc Toxicol       Date:  2011-06       Impact factor: 3.231

10.  Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.

Authors:  Calen P Ryan; Bernard J Crespi
Journal:  Evol Appl       Date:  2012-06-11       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.